Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Item
http://www.wikidata.org/entity/Q37164033
Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically.Sex differences among opioid-abusing patients with chronic pain in a clinical trial.Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic.Chronic Pain, Chronic Opioid Addiction: a Complex Nexus.Buprenorphine-naloxone therapy in pain management.Pressure sensitivity and phenotypic changes in patients with suspected opioid-induced hyperalgesia being withdrawn from full mu agonists.Therapies in early development for the treatment of opiate addiction.Chronic pain and opioid misuse: a review of reviewsVolatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.Opioid Use Disorder in Dental Patients: The Latest on How to Identify, Treat, Refer and Apply Laws and Regulations in Your Practice.The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
P2860

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Item
http://www.wikidata.org/entity/Q37164033
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Buprenorphine/naloxone as a pr ...... e liability of oral oxycodone.
@en
Buprenorphine/naloxone as a pr ...... e liability of oral oxycodone.
@nl
type
label
Buprenorphine/naloxone as a pr ...... e liability of oral oxycodone.
@en
Buprenorphine/naloxone as a pr ...... e liability of oral oxycodone.
@nl
prefLabel
Buprenorphine/naloxone as a pr ...... e liability of oral oxycodone.
@en
Buprenorphine/naloxone as a pr ...... e liability of oral oxycodone.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Buprenorphine/naloxone as a pr ...... e liability of oral oxycodone.
@en
P2093
P2860
P304
P31
P356
10.1016/J.PAIN.2013.05.004
P407
P433
P478
P50
P577
P5875
P698
P921
P932